These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 19953636

  • 1. A family harboring a germ-line N-terminal C/EBPalpha mutation and development of acute myeloid leukemia with an additional somatic C-terminal C/EBPalpha mutation.
    Nanri T, Uike N, Kawakita T, Iwanaga E, Mitsuya H, Asou N.
    Genes Chromosomes Cancer; 2010 Mar; 49(3):237-41. PubMed ID: 19953636
    [Abstract] [Full Text] [Related]

  • 2. Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia.
    Pabst T, Eyholzer M, Haefliger S, Schardt J, Mueller BU.
    J Clin Oncol; 2008 Nov 01; 26(31):5088-93. PubMed ID: 18768433
    [Abstract] [Full Text] [Related]

  • 3. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia.
    Pabst T, Mueller BU, Zhang P, Radomska HS, Narravula S, Schnittger S, Behre G, Hiddemann W, Tenen DG.
    Nat Genet; 2001 Mar 01; 27(3):263-70. PubMed ID: 11242107
    [Abstract] [Full Text] [Related]

  • 4. Mutations of CEBPA in acute myeloid leukemia FAB types M1 and M2.
    Snaddon J, Smith ML, Neat M, Cambal-Parrales M, Dixon-McIver A, Arch R, Amess JA, Rohatiner AZ, Lister TA, Fitzgibbon J.
    Genes Chromosomes Cancer; 2003 May 01; 37(1):72-8. PubMed ID: 12661007
    [Abstract] [Full Text] [Related]

  • 5. [Detection of CCAAT/enhancer binding protein alpha gene mutations in acute myeloid leukemia].
    Zhao JM, Wang HW, Xu ZF, Zhu L, Bai B, Ge XY.
    Zhonghua Xue Ye Xue Za Zhi; 2005 May 01; 26(5):299-302. PubMed ID: 15949295
    [Abstract] [Full Text] [Related]

  • 6. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.
    Pabst T, Mueller BU, Harakawa N, Schoch C, Haferlach T, Behre G, Hiddemann W, Zhang DE, Tenen DG.
    Nat Med; 2001 Apr 01; 7(4):444-51. PubMed ID: 11283671
    [Abstract] [Full Text] [Related]

  • 7. Mutation of CEBPA in familial acute myeloid leukemia.
    Smith ML, Cavenagh JD, Lister TA, Fitzgibbon J.
    N Engl J Med; 2004 Dec 02; 351(23):2403-7. PubMed ID: 15575056
    [Abstract] [Full Text] [Related]

  • 8. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50.
    Paz-Priel I, Cai DH, Wang D, Kowalski J, Blackford A, Liu H, Heckman CA, Gombart AF, Koeffler HP, Boxer LM, Friedman AD.
    Mol Cancer Res; 2005 Oct 02; 3(10):585-96. PubMed ID: 16254192
    [Abstract] [Full Text] [Related]

  • 9. Establishment of the acute myeloid leukemia cell line Kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of the C/EBPalpha gene.
    Asou H, Gombart AF, Takeuchi S, Tanaka H, Tanioka M, Matsui H, Kimura A, Inaba T, Koeffler HP.
    Genes Chromosomes Cancer; 2003 Feb 02; 36(2):167-74. PubMed ID: 12508245
    [Abstract] [Full Text] [Related]

  • 10. The emergence of a C/EBPalpha mutation in the clonal evolution of MDS towards secondary AML.
    Kaeferstein A, Krug U, Tiesmeier J, Aivado M, Faulhaber M, Stadler M, Krauter J, Germing U, Hofmann WK, Koeffler HP, Ganser A, Verbeek W.
    Leukemia; 2003 Feb 02; 17(2):343-9. PubMed ID: 12592334
    [Abstract] [Full Text] [Related]

  • 11. CEBPA polymorphisms and mutations in patients with acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin's lymphoma.
    Fuchs O, Provaznikova D, Kocova M, Kostecka A, Cvekova P, Neuwirtova R, Kobylka P, Cermak J, Brezinova J, Schwarz J, Markova J, Salaj P, Klamova H, Maaloufova J, Lemez P, Novakova L, Benesova K.
    Blood Cells Mol Dis; 2008 Feb 02; 40(3):401-5. PubMed ID: 18182175
    [Abstract] [Full Text] [Related]

  • 12. Aberrant DNA methylation of the transcription factor C/EBPalpha in acute myelogenous leukemia.
    Jost E, do O N, Wilop S, Herman JG, Osieka R, Galm O.
    Leuk Res; 2009 Mar 02; 33(3):443-9. PubMed ID: 18757096
    [Abstract] [Full Text] [Related]

  • 13. Characterization of CEBPA mutations in acute myeloid leukemia: most patients with CEBPA mutations have biallelic mutations and show a distinct immunophenotype of the leukemic cells.
    Lin LI, Chen CY, Lin DT, Tsay W, Tang JL, Yeh YC, Shen HL, Su FH, Yao M, Huang SY, Tien HF.
    Clin Cancer Res; 2005 Feb 15; 11(4):1372-9. PubMed ID: 15746035
    [Abstract] [Full Text] [Related]

  • 14. Rapid and sensitive screening for CEBPA mutations in acute myeloid leukaemia.
    Benthaus T, Schneider F, Mellert G, Zellmeier E, Schneider S, Kakadia PM, Hiddemann W, Bohlander SK, Feuring-Buske M, Braess J, Spiekermann K, Dufour A.
    Br J Haematol; 2008 Oct 15; 143(2):230-9. PubMed ID: 18752591
    [Abstract] [Full Text] [Related]

  • 15. A C-terminal mutant of CCAAT-enhancer-binding protein α (C/EBPα-Cm) downregulates Csf1r, a potent accelerator in the progression of acute myeloid leukemia with C/EBPα-Cm.
    Togami K, Kitaura J, Uchida T, Inoue D, Nishimura K, Kawabata KC, Nagase R, Horikawa S, Izawa K, Fukuyama T, Nakahara F, Oki T, Harada Y, Harada H, Aburatani H, Kitamura T.
    Exp Hematol; 2015 Apr 15; 43(4):300-8.e1. PubMed ID: 25534203
    [Abstract] [Full Text] [Related]

  • 16. Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia.
    Shih LY, Huang CF, Lin TL, Wu JH, Wang PN, Dunn P, Kuo MC, Tang TC.
    Clin Cancer Res; 2005 Mar 01; 11(5):1821-6. PubMed ID: 15756005
    [Abstract] [Full Text] [Related]

  • 17. Elevated c-Jun expression in acute myeloid leukemias inhibits C/EBPalpha DNA binding via leucine zipper domain interaction.
    Rangatia J, Vangala RK, Singh SM, Peer Zada AA, Elsässer A, Kohlmann A, Haferlach T, Tenen DG, Hiddemann W, Behre G.
    Oncogene; 2003 Jul 24; 22(30):4760-4. PubMed ID: 12879022
    [Abstract] [Full Text] [Related]

  • 18. Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
    Bienz M, Ludwig M, Leibundgut EO, Mueller BU, Ratschiller D, Solenthaler M, Fey MF, Pabst T.
    Clin Cancer Res; 2005 Feb 15; 11(4):1416-24. PubMed ID: 15746041
    [Abstract] [Full Text] [Related]

  • 19. C/EBPalpha in leukemogenesis: identity and origin of the leukemia-initiating cell.
    Schuster MB, Porse BT.
    Biofactors; 2009 Feb 15; 35(3):227-31. PubMed ID: 19322763
    [Abstract] [Full Text] [Related]

  • 20. Complexity of CEBPA dysregulation in human acute myeloid leukemia.
    Pabst T, Mueller BU.
    Clin Cancer Res; 2009 Sep 01; 15(17):5303-7. PubMed ID: 19706798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.